Oxford Growth Restriction Identification Programme (OxGRIP)
Research type
Research Study
Full title
Investigating the structured use of ultrasound scanning for fetal growth (Oxford Growth Restriction Identification Programme (OxGRIP)) on risk factors for and the incidences of adverse maternal, fetal and neonatal outcomes.
IRAS ID
222260
Contact name
Lawrence Impey
Contact email
Sponsor organisation
Oxford University Hospitals NHS Foundation Trust
Duration of Study in the UK
3 years, 0 months, 1 days
Research summary
In May 2016, the OUHFT introduced a new antenatal care pathway. This pathway is intended to increase the identification of babies who are at risk of stillbirth, in order to try to prevent this outcome, whilst making best usage of resources, and restricting inequitable practice and unnecessary obstetric intervention.
The principles of the pathway are
1) A universal routine scan at 36 weeks gestation.
2) Additional growth scans at 28 and 32 weeks gestation based on a simplified assessment of risk factors and universal uterine artery Doppler at 20 weeks gestation.
3) Assessment of further parameters other than estimated fetal weight associated with adverse perinatal outcome (eg growth velocity, umbilical artery Doppler and CPR)
Therefore, the rationale of this study will be to examine the impact of the new care pathway on the detection rate of babies at risk of stillbirth and the impacts on maternal and perinatal outcomes. It also seeks to assess the impact of the pathway on the maternity service and available resources.REC name
South Central - Hampshire A Research Ethics Committee
REC reference
17/SC/0374
Date of REC Opinion
26 Jul 2017
REC opinion
Favourable Opinion